Methoxyphenamine Hydrochloride
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB13624 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 29 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | osteoarthritis | KG + DL |
| 2 | alopecia | KG + DL |
| 3 | hypotrichosis simplex of the scalp | KG + DL |
| 4 | nephrogenic syndrome of inappropriate antidiuresis | KG + DL |
| 5 | congenital hypotrichosis milia | KG + DL |
| 6 | headache disorder | KG + DL |
| 7 | diffuse alopecia areata | KG + DL |
| 8 | benign prostatic hyperplasia (disease) | KG + DL |
| 9 | phaeochromocytoma | KG + DL |
| 10 | trigeminal autonomic cephalalgia | KG + DL |
| 11 | sympathetic paraganglioma | KG + DL |
| 12 | pseudoachondroplasia | KG + DL |
| 13 | osteoarthritis susceptibility | KG + DL |
| 14 | subarachnoid hemorrhage (disease) | KG + DL |
| 15 | autonomic nervous system neoplasm | KG + DL |
| 16 | common cold | KG + DL |
| 17 | non-secreting paraganglioma | KG + DL |
| 18 | acromesomelic dysplasia, Hunter-Thompson type | KG + DL |
| 19 | parasympathetic paraganglioma | KG + DL |
| 20 | brachyolmia | KG + DL |
| 21 | sporadic pheochromocytoma/secreting paraganglioma | KG + DL |
| 22 | myosclerosis | KG + DL |
| 23 | brachyolmia-amelogenesis imperfecta syndrome | KG + DL |
| 24 | small intestine cancer | KG + DL |
| 25 | adrenal gland pheochromocytoma | KG + DL |
| 26 | GTP cyclohydrolase I deficiency with hyperphenylalaninemia | KG + DL |
| 27 | arthropathy | KG + DL |
| 28 | insomnia (disease) | KG + DL |
| 29 | adrenal gland cancer | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.